Inventor · disambiguated record
Jorge Dimartino
Also filed as: DIMARTINO JORGE · DIMARTINO JORGE F
11 granted patents·11 pending applications·216 citations·filing 2001–2020
90Inventor score
Top patents by PatentIndex Score
22 records- 0196US6905669B2Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylaseSUPERGEN INC·Filed 2001·Granted Jun 14, 2005·138 cites·18 claims
- 0293US6613753B2Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2001·Granted Sep 2, 2003·43 cites·13 claims
- 0392US7276228B2Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylaseSUPERGEN INC·Filed 2005·Granted Oct 2, 2007·10 cites·16 claims
- 0484US9125884B2Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2012·Granted Sep 8, 2015·3 cites·22 claims
- 0581US9694015B2Methods for the treatment of locally advanced breast cancerCELGENE CORP·Filed 2013·Granted Jul 4, 2017·5 cites·17 claims
- 0681US7173016B2Composition and method for treating graft-versus-host diseaseMAYNE PHARMA USA INC·Filed 2005·Granted Feb 6, 2007·3 cites·37 claims
- 0780US10695352B2Combination therapy for treating malignanciesCELGENE CORP·Filed 2016·Granted Jun 30, 2020·4 cites·15 claims
- 0876US7037900B2Composition and method for treating graft-versus-host diseaseSUPERGEN INC·Filed 2001·Granted May 2, 2006·7 cites·39 claims
- 0974US10653710B2Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 19, 2020·2 cites·20 claims
- 1074US9693987B2Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2015·Granted Jul 4, 2017·1 cites·21 claims
- 1168US2008108559A1Compositions and methods for treating diseases through inhibition of dna methylation and histone deacetylaseDIMARTINO JORGE F·Filed 2007·Application pending·0 cites
- 1266US9101579B2Inhibition of drug resistant cancer cellsCELGENE CORP·Filed 2013·Granted Aug 11, 2015·0 cites·6 claims
- 1364US2004224919A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationFiled 2004·Application pending·0 cites
- 1464US2007066517A1Composition and method for treating graft-versus-host diseaseDIMARTINO JORGE·Filed 2006·Application pending·0 cites
- 1562US2004109846A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 1661US2004052864A1Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylationSUPERGEN INC·Filed 2003·Application pending·0 cites
- 1755US2021100805A1Combination therapy for treating malignanciesCELGENE CORP·Filed 2020·Application pending·0 cites
- 1854US2007105792A1Administration Of DNA Methylation Inhibitors For Treating Epigenetic DiseasesDIMARTINO JORGE F·Filed 2006·Application pending·0 cites
- 1953US2014357567A1Methods for treating cancers using oral formulations of cytidine analogsCELGENE CORP·Filed 2014·Application pending·0 cites
- 2052US2020405737A1Combination therapy for treating malignanciesAGIOS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2141US2015366936A1Inhibition of drug resistant cancer cellsCELGENE CORP·Filed 2015·Application pending·0 cites
- 2240US2015359810A1Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidineCELGENE CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jorge Dimartino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →